Copyright
©The Author(s) 2018.
World J Gastroenterol. Apr 7, 2018; 24(13): 1451-1463
Published online Apr 7, 2018. doi: 10.3748/wjg.v24.i13.1451
Published online Apr 7, 2018. doi: 10.3748/wjg.v24.i13.1451
Table 5 Multivariate analysis of overall survival in gallbladder cancer patients
| Characteristics | HR (95%CI) | Wald | P value |
| Resection margin status | 1.971 (1.288-3.017) | 0.002 | |
| Negative | |||
| Positive | |||
| TNM stage | 11.299 | 0.003 | |
| IIA-IIB stage/0-1 stage | 1.336 (0.317-5.627) | 0.156 | 0.693 |
| IIIA-IIIB stage/0-1 stage | 3.831 (1.167-12.571) | 4.907 | 0.027 |
| IVA-IVB stage/0-1 stage | 5.204 (1.497-18.093) | 6.730 | 0.009 |
| Fibrinogen concentration (g/L) | 1.711 (1.114-2.627) | 0.014 | |
| ≤ 3.47 | |||
| > 3.47 | |||
| CA199 (U/mL) | 1.842 (1.111-3.056) | 0.018 | |
| ≤ 25.45 | |||
| > 25.45 |
- Citation: Xu WY, Zhang HH, Yang XB, Bai Y, Lin JZ, Long JY, Xiong JP, Zhang JW, Sang XT, Zhao HT. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients. World J Gastroenterol 2018; 24(13): 1451-1463
- URL: https://www.wjgnet.com/1007-9327/full/v24/i13/1451.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i13.1451